MedPath

A study to associate aggressiveness of cholesteatoma

Not Applicable
Conditions
Health Condition 1: H711- Cholesteatoma of tympanum
Registration Number
CTRI/2022/04/041598
Lead Sponsor
DEAN Research committe
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ALL PATIENTS WITH CHRONIC OTITIS MEDIA SQUAMOSAL DISEASE WITH CHOLESTEATOMA

Exclusion Criteria

ALL PATIENTS WITH:

CHRONIC OTITIS MEDIA MUCOSAL DISEASE

EXTERNAL AUDITORY CANAL CHOLESTEATOMA

SKULL BASE OSTEOMYELITIS

SYSTEMIC INFLAMMATORY OR MALIGNANT CONDITIONS

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AGGRESSIVENESS OF CHOLESTEATOMA USING miRNA 21 and IL-6Timepoint: POST OPERATIVELY
Secondary Outcome Measures
NameTimeMethod
Correlation between Middle Ear Risk Index and miRNA 21 & IL-6 gene expressionTimepoint: Post surgery
© Copyright 2025. All Rights Reserved by MedPath